Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) Equity Average (2016 - 2025)

INVO Fertility (IVF) has disclosed Equity Average for 15 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average rose 532.76% to $4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.2 million, a 532.76% increase, with the full-year FY2024 number at $6.8 million, up 16187.72% from a year prior.
  • Equity Average was $4.2 million for Q3 2025 at INVO Fertility, up from $3.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $8.0 million in Q1 2025 to a low of -$808514.0 in Q2 2023.
  • A 5-year average of $2.9 million and a median of $3.0 million in 2025 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: crashed 128.7% in 2023, then surged 1681.08% in 2025.
  • INVO Fertility's Equity Average stood at $4.8 million in 2021, then plummeted by 96.8% to $154806.0 in 2022, then surged by 308.78% to $632812.0 in 2023, then skyrocketed by 905.37% to $6.4 million in 2024, then plummeted by 33.35% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Equity Average are $4.2 million (Q3 2025), $3.0 million (Q2 2025), and $8.0 million (Q1 2025).